Jane Avril: Toulouse-Lautrec’s favourite courtisan and Moulin Rouge’s choreic dancer
Objective: Our aim is to analyse selected portraits of Jane Avril, Moulin Rouge's most famous dancer, done by Toulouse-Lautrec, in which some features of chorea…Neurology Residents Versus a Mobile Medical Application in deducing differential diagnoses in Movement Disorders: A multi-center, cross-sectional, observational study
Objective: To test the hypothesis that the differentials generated by the Mobile Medical Application are more clinically relevant and complete to the ones derived by…Management of life threatening dyskinesias in GNAO1 related movement disorder: two new cases and review of the literature
Objective: To present two cases of GNAO1 related movement disorder associated with life threatening persistent chorea successfully managed with bilateral GPi deep brain stimulation (GPi-DBS)…Pediatric anti-N-methyl-D-aspartate receptor encephalitis associated with Coat’s-like retinal telangiectasia
Objective: We report a case of 5-year-old Indian boy with non-paraneoplastic anti NMDAR encephalitis associated with Coat's like retinal telangiectasia. Background: Anti-N-methyl-d-aspartate receptor (NMDAR) encephalitis…Novel compound heterozygous mutations in the TSFM gene causes childhood-onset chorea
Objective: To report the case of a young boy suffering from a severe hyperkinetic movement disorder caused by mutations in the recently described TSFM gene.…Salivary biomarkers for Huntington’s disease (HD)
Objective: The objective of the current study was to assess the potential for saliva to serve as a biospecimen for accessible biomarkers for Huntington’s disease…Dynamic prediction of motor diagnosis in Huntington’s disease using a joint modeling approach
Objective: Compare various clinical and biomarker trajectories for tracking Huntington's disease (HD) progression and predicting motor conversion. Background: Huntington’s disease (HD) is a fatal neurodegenerative disease…Loss of PDE10A expression in patients with PDE10A and ADYC5 mutations
Objective: To assess phosphodiesterase 10A (PDE10A) expression in vivo, using [11C]IMA107 PET in patients with PDE10A and adenylate cyclase 5 (ADYC5) mutations. Background: Cyclic adenosine…The Long-Term Safety of Deutetrabenazine for Chorea in Huntington Disease
Objective: To evaluate the safety and tolerability of deutetrabenazine in Huntington Disease (HD) over long term exposure. Background: In a randomized, double-blind, controlled trial (First-HD),…Clinical and genetic characterization of Huntington’s disease in relation to the age and type of onset.
Objective: To describe the clinical features and CAG repeats in a large population of Mexican patients with Huntington's disease and its relation to the age…
- 1
- 2
- 3
- …
- 11
- Next Page »